289 related articles for article (PubMed ID: 35149974)
1. Factors Influencing Alzheimer's Disease Risk: Whether and How They are Related to the APOE Genotype.
Zhang R; Xu X; Yu H; Xu X; Wang M; Le W
Neurosci Bull; 2022 Jul; 38(7):809-819. PubMed ID: 35149974
[TBL] [Abstract][Full Text] [Related]
2. APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease.
Ayyubova G
CNS Neurol Disord Drug Targets; 2024; 23(3):342-352. PubMed ID: 36872358
[TBL] [Abstract][Full Text] [Related]
3. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E levels in the cerebrospinal fluid of north Indian patients with Alzheimer's disease.
Kandimalla RJ; Wani WY; Anand R; Kaushal A; Prabhakar S; Grover VK; Bharadwaj N; Jain K; Gill KD
Am J Alzheimers Dis Other Demen; 2013 May; 28(3):258-62. PubMed ID: 23612909
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
6. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
7. Relationship of Apolipoprotein E with Alzheimer's Disease and Other Neurological Disorders: An Updated Review.
Lou T; Tao B; Chen M
Neuroscience; 2023 Mar; 514():123-140. PubMed ID: 36736614
[TBL] [Abstract][Full Text] [Related]
8. Combined effect of apolipoprotein e genotype and past fertility on age at onset of Alzheimer's disease in women.
Corbo RM; Gambina G; Ulizzi L; Monini P; Broggio E; Rosano A; Scacchi R
Dement Geriatr Cogn Disord; 2007; 24(2):82-5. PubMed ID: 17565217
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease: clinical implications of the apolipoprotein E genotype.
Farlow MR
Neurology; 1997 May; 48(5 Suppl 6):S30-4. PubMed ID: 9153158
[TBL] [Abstract][Full Text] [Related]
10. Race-Related Association between APOE Genotype and Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Qin W; Li W; Wang Q; Gong M; Li T; Shi Y; Song Y; Li Y; Li F; Jia J
J Alzheimers Dis; 2021; 83(2):897-906. PubMed ID: 34334408
[TBL] [Abstract][Full Text] [Related]
11. Clinical Application of APOE in Alzheimer's Prevention: A Precision Medicine Approach.
Berkowitz CL; Mosconi L; Rahman A; Scheyer O; Hristov H; Isaacson RS
J Prev Alzheimers Dis; 2018; 5(4):245-252. PubMed ID: 30298183
[TBL] [Abstract][Full Text] [Related]
12. Current understanding of the interactions between metal ions and Apolipoprotein E in Alzheimer's disease.
Zhang Y; Gao H; Zheng W; Xu H
Neurobiol Dis; 2022 Oct; 172():105824. PubMed ID: 35878744
[TBL] [Abstract][Full Text] [Related]
13. Novel Alzheimer's disease risk variants identified based on whole-genome sequencing of APOE ε4 carriers.
Park JH; Park I; Youm EM; Lee S; Park JH; Lee J; Lee DY; Byun MS; Lee JH; Yi D; Chung SJ; Park KW; Choi N; Kim SY; Yoon W; An H; Kim KW; Choi SH; Jeong JH; Kim EJ; Kang H; Lee J; Kim Y; Lee EA; Seo SW; Na DL; Kim JW
Transl Psychiatry; 2021 May; 11(1):296. PubMed ID: 34011927
[TBL] [Abstract][Full Text] [Related]
14. The Roles of Apolipoprotein E, Lipids, and Glucose in the Pathogenesis of Alzheimer's Disease.
Shinohara M; Sato N
Adv Exp Med Biol; 2019; 1128():85-101. PubMed ID: 31062326
[TBL] [Abstract][Full Text] [Related]
15. Predictive metabolic networks reveal sex- and APOE genotype-specific metabolic signatures and drivers for precision medicine in Alzheimer's disease.
Chang R; Trushina E; Zhu K; Zaidi SSA; Lau BM; Kueider-Paisley A; Moein S; He Q; Alamprese ML; Vagnerova B; Tang A; Vijayan R; Liu Y; Saykin AJ; Brinton RD; Kaddurah-Daouk R;
Alzheimers Dement; 2023 Feb; 19(2):518-531. PubMed ID: 35481667
[TBL] [Abstract][Full Text] [Related]
16. APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease.
Reinvang I; Espeseth T; Westlye LT
Neurosci Biobehav Rev; 2013 Sep; 37(8):1322-35. PubMed ID: 23701948
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease.
Hyman BT; Gomez-Isla T; Rebeck GW; Briggs M; Chung H; West HL; Greenberg S; Mui S; Nichols S; Wallace R; Growdon JH
Ann N Y Acad Sci; 1996 Dec; 802():1-5. PubMed ID: 8993478
[TBL] [Abstract][Full Text] [Related]
18. Prospective Belgian study of neurodegenerative and vascular dementia: APOE genotype effects.
Engelborghs S; Dermaut B; Goeman J; Saerens J; Mariën P; Pickut BA; Van den Broeck M; Serneels S; Cruts M; Van Broeckhoven C; De Deyn PP
J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1148-51. PubMed ID: 12876259
[TBL] [Abstract][Full Text] [Related]
19. Evidence in support of chromosomal sex influencing plasma based metabolome vs APOE genotype influencing brain metabolome profile in humanized APOE male and female mice.
Shang Y; Mishra A; Wang T; Wang Y; Desai M; Chen S; Mao Z; Do L; Bernstein AS; Trouard TP; Brinton RD
PLoS One; 2020; 15(1):e0225392. PubMed ID: 31917799
[TBL] [Abstract][Full Text] [Related]
20. APOE and Alzheimer's Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer's Pathogenesis.
Uddin MS; Kabir MT; Al Mamun A; Abdel-Daim MM; Barreto GE; Ashraf GM
Mol Neurobiol; 2019 Apr; 56(4):2450-2465. PubMed ID: 30032423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
